Cargando…

Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy in women worldwide, with an overall 5 year survival rate below 30%. The low survival rate is associated with the persistence of cancer stem cells (CSCs) after chemotherapy. Therefore, CSC-targeting strategies are required fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Heejin, Kim, Jun Woo, Lee, Dong-Seok, Min, Sang-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583017/ https://www.ncbi.nlm.nih.gov/pubmed/33036254 http://dx.doi.org/10.3390/ijms21197379

Ejemplares similares

Dissolution method for delapril and manidipine combination tablets based on an absorption profile of manidipine()
por: Todeschini, Vítor, et al.
Publicado: (2016)

Manidipine–delapril combination in the management of hypertension
por: Luque Otero, Manuel
Publicado: (2007)

Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells
por: Lee, Heejin, et al.
Publicado: (2021)

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer
por: McCorkle, J. Robert, et al.
Publicado: (2021)

Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells
por: Lee, Heejin, et al.
Publicado: (2020)

Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
por: Ji, Weiping, et al.
Publicado: (2021)

Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
por: Kim, Tae Min, et al.
Publicado: (2018)

PCL/PHBV Microparticles as Innovative Carriers for Oral Controlled Release of Manidipine Dihydrochloride
por: Barboza, Fernanda Malaquias, et al.
Publicado: (2014)

Diffuse scaly erythematous plaques in patient taking poziotinib
por: Oldenburg, Reid, et al.
Publicado: (2021)

Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes
por: SaizSatjes, Margarita, et al.
Publicado: (2018)

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
por: Lee, Ji Hyun, et al.
Publicado: (2021)

Efficacy and safety profiles of manidipine compared with amlodipine: A meta-analysis of head-to-head trials
por: RICHY, FLORENT F, et al.
Publicado: (2011)

Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC‐MS/MS
por: Wang, Shuanghu, et al.
Publicado: (2023)

Poziotinib Inhibits HER2-Mutant–Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer
por: Kalra, Rashi, et al.
Publicado: (2022)

Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo
por: Zhou, Shan, et al.
Publicado: (2023)

A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors
por: Han, Ji-Youn, et al.
Publicado: (2017)

Effects of Bambusa tulda on the proliferation of human stem cells
por: Lee, Hyunjin, et al.
Publicado: (2017)

Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
por: Wang, Jinhui, et al.
Publicado: (2021)

Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice
por: Yoon, Sook Young, et al.
Publicado: (2020)

Downregulation of ADAMTS3 Suppresses Stemness and Tumorigenicity in Glioma Stem Cell
por: Kim, Hyun‐Jin, et al.
Publicado: (2022)

Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell
por: Lee, Hyun-Gyo, et al.
Publicado: (2017)

Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cells
por: YAN, HONG CHAO, et al.
Publicado: (2015)

Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
por: Tchekmedyian, Nishan, et al.
Publicado: (2020)

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
por: Zhang, Yongchao, et al.
Publicado: (2020)

Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness
por: Li, Yucong, et al.
Publicado: (2020)

Hypoxia Upregulates Mitotic Cyclins Which Contribute to the Multipotency of Human Mesenchymal Stem Cells by Expanding Proliferation Lifespan
por: Lee, Janet, et al.
Publicado: (2018)

Kuwanon V Inhibits Proliferation, Promotes Cell Survival and Increases Neurogenesis of Neural Stem Cells
por: Kong, Sun-Young, et al.
Publicado: (2015)

Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation
por: Prelaj, Arsela, et al.
Publicado: (2022)

Unraveled roles of Cav1.2 in proliferation and stemness of ameloblastoma
por: Li, Shujin, et al.
Publicado: (2022)

Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain
por: Kang, Hyeok Gu, et al.
Publicado: (2016)

Betulinic Acid Suppresses Ovarian Cancer Cell Proliferation through Induction of Apoptosis
por: Lee, Dahae, et al.
Publicado: (2019)

Nuclear Factor I-C Regulates Stemness Genes and Proliferation of Stem Cells in Various Mineralized Tissue through Epithelial-Mesenchymal Interactions in Dental Epithelial Stem Cells
por: Lee, Dong-Seol, et al.
Publicado: (2022)

Poziotinib in non-small-cell lung cancer patients with HER2 exon 20 mutations: A pooled analysis of randomized clinical trials
por: Wang, Bi-Cheng, et al.
Publicado: (2022)

TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells
por: Kang, Kyung Taek, et al.
Publicado: (2018)

Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells()()
por: Lee, Yong Sang, et al.
Publicado: (2018)

Evodiamine Eliminates Colon Cancer Stem Cells via Suppressing Notch and Wnt Signaling
por: Kim, Hyejin, et al.
Publicado: (2019)

Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin
por: Gu, Yan-hui, et al.
Publicado: (2021)

Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer
por: Tang, Bin, et al.
Publicado: (2023)

Effects of coenzyme Q10 on ovarian surface epithelium-derived ovarian stem cells and ovarian function in a 4-vinylcyclohexene diepoxide-induced murine model of ovarian failure
por: Lee, Hyun Joo, et al.
Publicado: (2021)

S100A8 accelerates wound healing by promoting adipose stem cell proliferation and suppressing inflammation
por: Su, WeiGuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nngl9erokft16q4b8e2497421n